Coronary stent Nano+™

stainless steelhydrophilic

Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion. Vacuum drug coating technology ensures complete drug dosage and coating stability. Post-treatment after drug loading helps with sustained drug release. Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability. Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion. Patented hydrophilic coating on distal shaft provides outstanding pushability. Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety. Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time. The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis. An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety Prouduct Features Polymer-free DES Nanoporous drug carrier on abluminal surface Balanced strut thickness High radial force Sine wave + 3-3-3 link Double helix structure Large open cell Precise positioning markers Effective drug of Sirolimus Vacuum drug coating technology 90-day drug releasing period New delivery system Prouduct Benefits Significantly shorten DAPT time Earlier & better endothelialization Highly reduced risk of thrombosis Great deliverability Easy positioning and placement Optimal tissue scaffolding Excellent side branch access Scientific drug releasing period